Maija Saraste
maihel@utu.fi +358 29 450 4743 +358 50 472 8266 Itäinen Pitkäkatu 4 Turku |
Publications
- Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study (2026)
- Journal of Neurology
(A1 Refereed original research article in a scientific journal) - Multiple sclerosis: 2024 update (2025)
- Free Neuropathology
(A2 Refereed review article in a scientific journal ) - Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)
- Journal of Neurology, Neurosurgery and Psychiatry
(A1 Refereed original research article in a scientific journal) - Predictors of risk of secondary progression in multiple sclerosis (2025)
- Therapeutic Advances in Neurological Disorders
(A1 Refereed original research article in a scientific journal) - Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain (2025)
- Therapeutic Advances in Neurological Disorders
(A1 Refereed original research article in a scientific journal) - A Novel Comprehensive Epigenomic Liquid Biopsy Assay Reveals Disease Biology in Multiple Sclerosis Patients from 1 mL of Plasma (2024)
- Multiple Sclerosis
(Abstract) - Plasma CHI3L1 associates with increased TSPO-PET measurable microglial activation in patients with progressive multiple sclerosis (2024)
- Multiple Sclerosis
(Poster) - Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)
- Frontiers in Neurology
(A1 Refereed original research article in a scientific journal) - TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)
- Multiple Sclerosis
(Poster) - Association of serum neurofilament light with microglial activation in multiple sclerosis (2023)
- Journal of Neurology, Neurosurgery and Psychiatry
(A1 Refereed original research article in a scientific journal)



